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Abstract
Background Caesarean section (CS) has been reported to increase the risk of asthma in
offspring. This may be due to that infants delivered by CS are unexposed to vaginal flora,
according to the ‘hygiene hypothesis’.
Objective Our aim was to investigate if CS increases risk of childhood asthma, and if the
risk increase remains after adjustment for familial confounding using sibling design.
Methods A register-based cohort study with 87 500 Swedish sibling pairs was undertaken.
Asthma outcome variables were collected from national health registers as diagnosis or
asthma medication (ICD-10 J45-J46; ATC code R03) during the 10th or 13th year of life
(year of follow-up). Mode of delivery and confounders were retrieved from the Medical
Birth Register. The data were analysed both as a cohort and with sibling control analysis
which adjusts for unmeasured familial confounding.
Results In the cohort analyses, there was an increased risk of asthma medication and
asthma diagnosis during year of follow-up in children born with CS (adjusted ORs, 95%
CI 1.13, 1.04–1.24 and 1.10, 1.03–1.18 respectively). When separating between emergency
and elective CS the effect on asthma medication remained for emergency CS, but not for
elective CS, while both groups had significant effects on asthma diagnosis compared with
vaginal delivery. In sibling control analyses, the effect of elective CS on asthma disap-
peared, while similar but non-significant ORs of medication were obtained for emergency
CS.
Conclusions and Clinical Relevance An increased risk of asthma medication in the group
born by emergency CS, but not elective, suggests that there is no causal effect due to
vaginal microflora. A more probable explanation should be sought in the indications for
emergency CS.
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Introduction
The prevalence of childhood asthma and allergic disease
increased up to recently in many nations around the
world, which implies that a substantial proportion of
the risk of having the disease is attributable to environ-
mental factors [1, 2]. Pre- and perinatal etiological fac-
tors are of great importance, and recent findings have
shown that fetal growth affects the susceptibility to
asthma [3] and eczema [4]. There has also been a large
interest in the impact of mode of delivery on the devel-
opment of asthma. Recent meta-analyses reported a
20% increase in the subsequent risk of asthma in chil-
dren who had been delivered by Caesarean section (CS)
[5, 6] and a moderate risk increase for allergic rhinitis
and asthma [7]. However, results are conflicting; some
recent articles have reported children born with CS to
have an increased risk of asthma [8–10] whereas others
found no such associations [11–14].
The rationale why CS could increase the risk of
asthma has been referred to a modified intestinal
microflora in those unexposed to the vaginal flora,
according to the ‘hygiene hypothesis’ [15]. It has
also been recently shown by Schlintzig et al. that
DNA-methylation is higher in infants delivered by CS
than in vaginally delivered infants [16]. However, as CS
is commonly performed because of concern of maternal
and fetal health, a possible association between CS and
risk of asthma in offspring may be explained by the
underlying indications for CS [17, 18]. These could be
related to choice of elective CS (anxious mother,
anthropometric measures or obstetric history), emer-
gency situations (prematurity, prolonged parturition or
fetal asphyxia) or subsequent diagnoses including early
respiratory stress. The association between mode of
delivery and asthma and its possible mechanisms can
be studied in a dataset where vaginal delivery (VD) is
separate from vaginal instrumental delivery, CS can be
subdivided into emergency CS and elective CS and
unmeasured familial confounding can be taken into
consideration using sibling controls. Sibling studies
provide an excellent opportunity to study the associa-
tion between CS and asthma, controlling for shared
(familial) environmental and genetic factors. Siblings
share half of their genes, some intrauterine exposures,
maternal factors and early environment including
socio-economic factors, diet and lifestyle. In addition,
siblings may be discordant regarding mode of delivery.
If associations seen in a cohort of siblings remain in
sibling control analyses, then factors specific to each
individual (such as exposure to vaginal flora or the
indication for mode of delivery) are involved in the
underlying causal pathways. Conversely, if the relation-
ships disappear or substantially diminish in sibling con-
trol analyses, then factors common to the siblings (such
as maternal factors) may be involved.
The aim of this study was to examine the impact of
mode of delivery on the prevalence of asthma in child-
hood and adolescence and the causal mechanism
behind a possible link, including sibling analyses to
control for unmeasured familial confounding. We used
a sibling population with data on mode of delivery and
other perinatal exposures as well as asthma medication
and specialist care diagnoses from the Swedish national
health registers.
Material and methods
Study design and population
A population-based follow-up study based on the
Swedish national registers held by the Swedish National
Board of Health and Welfare and Statistics Sweden was
conducted. The universal use of the Personal Identity
Number (PIN), a unique identifier for each resident,
enables unambiguous linkage between the registers
[19]. All children born in Sweden from June 1993 to
June 1999 were identified through the Medical Birth
Register, which contains maternal and child characteris-
tics data on > 98% of all births in Sweden. Information
on mother’s country of birth and family relationships
was retrieved from the Multi-Generation Register, which
contains links between parent and child, and vital sta-
tistics were retrieved from the Total Population Register.
The cohort was limited to the first two siblings of
mothers who had given birth to those two children
within the allocated time frame. There were 93 740 sib-
ling pairs born June 1993–June 1999. After exclusion
of pairs with at least one child coming from a multiple
birth (n = 1784), pairs with one sibling deceased before
end of follow-up (n = 776), pairs with at least one sib-
ling without record in the Medical Birth Register
(n = 2300) and pairs with at least one sibling having
contradictory or unclear information on mode of deliv-
ery in the Medical Birth Register (n = 1325, mainly CS
which could not be classified), 87 555 sibling pairs
(175 110 children) remained in the cohort.
The cohort was linked to the Prescribed Drug Register
(PDR) which contains all prescribed drugs dispensed
since July 1, 2005 and the National Patient Register
(NPR) which covers all in-patient care in Sweden from
1987 and 75% of all outpatient visits since 2001.
Variables
Birth outcomes. Information on child (birth weight,
gestational age [GA], gender, Apgar score and maternal
characteristics (age, parity, smoking, family situation,
height and weight) was obtained from the Medical Birth
Register. In Sweden, early second trimester ultrasonog-
raphy to estimate GA is routinely offered since 1990,
and 95% of women accept this offer, otherwise the date
of the last menstrual period is used [20]. Apgar score at
5 min was categorized as 0–3, 4–6 and 7–10. Maternal
age and parity were recorded at delivery. Mother’s
smoking habits (0, 1–9 or  10 cigarettes per day) and
family situation (cohabits with child’s father yes/no)
were registered at first visit to the antenatal-care clinic
in week 8–12, along with height and weight, used for
calculation of body mass index, kg/m2 [BMI]. Mode of
delivery was defined as either VD or CS. Elective CS
was defined as CS before onset of labour and emer-
gency as CS after onset of labour. Instrumental delivery
(vacuum extraction or forceps) was also noted.
Information on type of siblingship; full or half (same
mother, different father) and birth order (first or second)
was obtained through linkage with the Multi-Genera-
tion register.
Asthma medication and diagnosis. Dispensed asthma
medications were retrieved from the PDR. In our analy-
ses we had two asthma outcome variables based on
medication; (1) any asthma medication (ATC codes
R03CC, R03AC, R03BA, R03AK, R03DC) and (2) any
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asthma medication except oral b2-agonists, dispensed at
least twice during the year of follow up; during the
13th year of life for children born June 1993–May
1996 and during the 10th year of life for those born
June 1996–June 1999. A third outcome variable was
based on diagnoses of asthma in the NPR (ICD-9 codes
493 and ICD-10 codes J45, J46), during the year of
follow up.
Statistical analyses
The statistical analyses were performed in two steps.
First, the associations between asthma medication and
mode of delivery were analysed treating the study
group as a cohort, with asthma medication and
asthma diagnosis as outcome variables using general-
ized estimating equations (with the logit link) to
account for the correlation within sibling pairs. Odds
ratios and 95% confidence intervals are reported both
as crude and adjusted for the child characteristics
gender, birth order, birth weight, GA and Apgar score
at 5 min as well as the maternal characteristics age at
delivery, smoking during pregnancy, mother living
with father of the child, mother’s birth country and
mother’s BMI.
Secondly, to adjust for familial environmental con-
founding and partly for genetic factors, sibling analyses
were performed, using conditional logistic regression
within siblings who were discordant for both mode of
delivery (i.e. discordant for the four level mode of
delivery variable) and the outcome variable. The paired
analyses were adjusted for the same variables as the
cohort analyses, except mother’s birth country, which is
the same for both siblings. Furthermore, the conditional
analysis produces estimates that are adjusted for all the
unmeasured familial factors that siblings have in com-
mon, but which are difficult to measure, e.g. parental
factors, home environment, life style and to some
extent genes. SAS version 9.2 was used for all analyses.
Permission for the study was obtained from the
Regional Ethical Review board in Stockholm, Sweden.
Results
In the main sibling population, 9.4% were delivered
with CS, of which 5.4% were emergency and 4.2% elec-
tive caesareans. There were 7.6% vaginal instrumental
deliveries (7.1% vacuum extractions [VE] and 0.5% for-
ceps). In 20 493 sibling pairs, siblings were born with
different modes of delivery. This group of siblings were
thus discordant for mode of delivery, and used in the
sibling analyses below. In total, 7.0% of the children
had any asthma medication (6.8% of those delivered
with VD, 7.9% if elective CS and 8.2% if born with
emergency CS) and 1.6% of the children had an asthma
diagnosis (1.5% of those delivered with VD, 2.0% if
elective CS and 2.1% if born with emergency CS).
Table 1 shows child characteristics at birth, subse-
quent asthma medication and asthma diagnoses,
siblingship and maternal characteristics for the full
cohort of children and the group discordant for mode
of delivery. In the full cohort, both elective and emer-
gency CS were more common in children with low birth
weight, short GA and low Apgar scores. The CS group
had slightly more dispensed asthma medication and
diagnoses of asthma. Both elective and emergency CS
rates increased with maternal age and BMI. In the
group of siblings with discordant mode of delivery, the
pattern was almost identical.
Table 2 presents a cohort analysis on the associations
between mode of delivery and the outcomes (asthma
medication and asthma diagnoses). When asthma was
defined as having taken asthma medication at least
twice, there was an increased risk of asthma in children
born with CS (OR 1.20, 95% CI 1.11–1.29) in the crude
analysis, which remained after adjustment for potential
confounders (OR 1.13, 95% CI 1.04–1.24). For asthma
diagnosis during the follow-up year, crude and adjusted
ORs were also increased (ORs 1.32, 95% CI 1.18–1.48
and 1.20, 95% CI 1.05–1.37 respectively).
In Table 3, the CS group was stratified into emer-
gency and elective CS, to study whether the CS per se
or the indicators for CS where important for asthma
risk in the whole cohort. The estimates remained stable
for emergency CS, but were slightly lower and gener-
ally not statistically significant for elective CS. Also, we
compared VS with instrumental VD and found no
difference.
A comparison between VD born children with VD
and CS siblings and CS born children with VD and CS
siblings showed very similar prevalence between all
groups except CS born children with CS siblings, who
had statistically significantly higher odds of diagnosis
during follow-up compared with the other groups (data
not shown). This pattern was not as apparent for the
other outcome variables.
Table 4 shows results from the sibling control analy-
sis, i.e. the sibling pairs with discordant mode of deliv-
ery and asthma status, which by design adjusts for
shared familial factors. There was a borderline increased
risk of asthma medication at least twice in children
born with emergency CS (adjusted OR 1.24, 95% CI
0.99–1.60) but not significant for elective CS (OR 0.82,
95% CI 0.64–1.09). Similarly, there was a borderline
increased risk of any asthma medication in children
born with emergency CS (OR 1.19, 95% CI 0.98–1.44).
For asthma diagnosis during the year of follow-up, ORs
were equally non-significant after adjustment. The dif-
ference in effect between emergency vs. elective CS was
statistically significant, P = 0.0033.
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Table 1. Study population characteristics by mode of delivery in a cohort of 175 110 Swedish children in sibling pairs, born June 1993–June
1999, and in a subset of the cohort with 40 986 siblings in pairs discordant regarding mode of delivery
Mode of delivery
Full cohort Children in discordant pairs
N Vaginal
Vaginal with
instrument
Caesarean,
emergency
Caesarean,
elective N Vaginal
Vaginal with
instrument
Caesarean,
emergency
Caesarean,
elective
N 175 110 83.0 7.6 5.2 4.2 40 986 40.5 29.5 16.4 13.7
Child’s characteristics
Birth weight (grams)
 2999 20 898 76.4 6.4 7.4 9.8 5700 28.9 21.7 22.2 27.2
3000–3499 55 556 84.8 7.1 3.9 4.2 11 730 41.2 30.3 14.0 14.6
3500–3999 63 967 84.7 7.9 4.5 2.9 14 370 43.5 31.7 14.5 10.3
4000–4499 27 872 82.2 8.8 6.4 2.7 7068 43.4 31.3 16.8 8.5
 4500 6195 75.4 8.8 11.2 4.6 1928 38.9 24.3 25.4 11.5
Missing 622 75.6 8.8 6.8 8.8 190 35.8 24.2 16.8 23.2
Gestational age (weeks)
 34 2371 54.7 2.9 12.2 30.2 1047 16.2 6.1 23.4 54.3
35–36 4903 76.9 5.2 8.2 9.6 1305 29.9 17.5 25.0 27.7
37–38 29 671 77.3 4.8 4.4 13.5 7566 30.3 16.9 13.0 39.9
39–40 93 562 87.3 7.1 3.9 1.7 19 023 48.2 31.5 13.6 6.8
41–42 43 428 80.2 11.1 7.7 1.1 11 623 38.6 37.4 20.9 3.1
 43 1048 64.9 15.7 17.6 1.8 384 21.6 40.6 34.4 3.4
Missing 127 78.7 6.3 7.9 7.1 38 44.7 18.4 18.4 18.4
Gender
Male 89 930 81.7 8.6 5.7 4.1 21 804 38.2 31.8 17.2 12.9
female 85 180 84.3 6.7 4.8 4.3 19 182 43.2 26.8 15.4 14.6
APGAR score at 5 min
 3 399 65.2 12.0 14.3 8.5 150 30.7 26.7 26.0 16.7
4–7 2456 46.6 24.7 20.4 8.3 1267 15.5 41.6 30.5 12.4
8–10 170 914 83.5 7.4 5.0 4.1 39 265 41.3 29.2 15.8 13.7
Missing 1341 83.5 4.9 6.0 5.6 304 45.4 19.7 18.1 16.8
Any asthma medication
No 162 850 83.1 7.6 5.2 4.1 37 922 40.7 29.4 16.2 13.7
Yes 12 260 81.0 8.2 6.1 4.7 3064 38.0 30.1 17.9 14.1
Asthma medication other than oral b2-agonists at least twice in 12 months
No 167 483 83.0 7.6 5.2 4.1 39 051 40.6 29.5 16.4 13.7
Yes 7627 80.9 8.1 6.1 5.2 1935 38.0 29.2 18.4 14.4
Asthma diagnosis in specialist care during 12 months followup†
No 172 324 83.0 7.6 5.2 4.2 40 273 40.7 29.4 16.3 13.7
Yes 2786 78.9 9.0 6.9 5.2 713 31.8 33.0 20.6 14.6
Type of siblingship
Full 171 016 82.9 7.7 5.2 4.2 40 136 40.5 29.5 16.3 13.7
Half ‡ 4094 84.4 6.6 5.1 3.9 850 42.5 27.7 16.9 12.9
Birth order
First 87 555 77.0 12.6 7.1 3.2 20 493 15.0 50.8 24.5 9.7
Second 87 555 88.9 2.7 3.3 5.1 20 493 66.0 8.1 8.2 17.7
Mother’s characteristics
Mother’s age at delivery (years)
 19 3985 87.1 6.8 3.9 2.3 622 25.6 41.8 21.2 11.4
20–24 39 727 85.2 7.4 4.6 2.8 7618 32.8 36.1 19.3 11.8
25–29 73 309 83.7 7.8 5.0 3.6 16 327 39.5 31.5 16.6 12.4
30–34 46 125 81.5 7.6 5.7 5.3 12 375 45.3 24.9 14.6 15.2
 35 11 964 75.8 8.2 7.2 8.9 4044 46.8 20.4 14.5 18.2
(continued)
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Discussion
In a cohort analysis of 87 555 sibling pairs born 1993–
1999, we found an increased risk of asthma in children
born with CS. We also found that emergency CS, but not
elective CS, was associated with increased risk of asthma,
even when we had the best possible controls and
adjusted for unmeasured familial confounding in the sib-
ling analyses. Thus our results, based on the largest pop-
ulation-based register linkage study on mode of delivery
Table 1 (continued)
Mode of delivery
Full cohort Children in discordant pairs
N Vaginal
Vaginal with
instrument
Caesarean,
emergency
Caesarean,
elective N Vaginal
Vaginal with
instrument
Caesarean,
emergency
Caesarean,
elective
Smoking during pregnancy (cigarettes per day)
0 148 546 83.2 7.7 5.1 4.1 34 608 40.9 29.6 16.1 13.4
1–9 13 059 81.2 8.6 5.7 4.5 3133 35.1 32.4 18.0 14.5
 10 5447 82.6 7.1 5.9 4.4 1265 37.5 28.0 20.4 14.2
Missing 8058 83.0 6.4 5.3 5.4 1980 43.8 22.8 16.0 17.4
Cohabits with child’s father
Yes 160 593 83.1 7.6 5.2 4.2 37 633 40.9 29.3 16.1 13.7
No 4635 82.4 9.2 5.2 3.3 999 31.2 38.4 18.9 11.5
Missing 9882 82.0 7.6 5.8 4.7 2354 38.1 28.2 18.6 15.2
Country of birth
Sweden 119 968 81.8 8.9 5.6 3.2 27 822 34.2 35.3 18.4 12.1
Nordic
country
3299 81.0 8.1 5.9 3.7 840 40.7 27.5 18.0 13.8
Other 51 654 85.9 4.7 4.3 5.0 12 279 54.8 16.4 11.6 17.2
Missing 189 85.7 6.9 4.2 5.1 45 48.9 26.7 11.1 13.3
BMI (kg/m2)
< 18.5 4606 86.1 7.3 3.3 3.3 898 40.4 33.2 13.8 12.6
18.5–24.9 101 676 84.1 7.7 4.5 3.7 22 416 40.0 31.7 15.6 12.8
25–29.9 31 414 81.2 7.4 6.5 4.9 8227 43.0 25.1 17.4 14.6
 30 9850 77.7 7.2 8.6 6.5 2896 41.5 22.1 19.3 17.1
Missing 27 564 82.1 8.0 5.4 4.5 6549 38.7 30.2 16.9 14.3
†13th year of life for children born June 1993–May 1996, 10th year of life for children born June 1996–June 1999.
‡Same mother, different fathers.
Table 2. Odds ratios and 95% confidence interval of association between mode of delivery and (i) filled prescriptions of asthma medication at age
9–12 years§ and (ii) asthma diagnosis, in a cohort of children born in Sweden in June 1993–June 1999
Mode of
delivery
Model A*
(n = 175 110)
Model B†
(n = 174 381)
Model C‡
(n = 139 610)
Any asthma
medication
Vaginal Ref Ref Ref
Caesarean 1.18 (1.11–1.25) 1.13 (1.06–1.20) 1.10 (1.03–1.18)
b2-agonists,
corticosteroids or
montelucast,
at least twice
Vaginal Ref Ref Ref
Caesarean 1.20 (1.11–1.29) 1.15 (1.06–1.24) 1.13 (1.04–1.24)
Asthma diagnosis
during follow up
year§
Vaginal Ref Ref Ref
Caesarean 1.32 (1.18–1.48) 1.23 (1.10–1.39) 1.20 (1.05–1.37)
*Adjusted for gender.
†Adjusted for gender, birth weight and gestational age.
‡Adjusted for gender, birth weight, gestational age, birth order, APGAR score, hypoxia/asphyxia, mother’s age, smoking during pregnancy, mother
living with father of the child, mother’s birth country and mother’s BMI.
§13th year of life for children born June 1993–May 1996, 10th year of life for children born June 1996–June 1999.
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and asthma to date, support the hypothesis that CS per se
does not increase the risk of subsequent asthma, but
could be explained by the reason for CS, such as factors
related to maternal or foeto-infant health.
Previous studies have shown an increased risk of
asthma with CS [8–10, 21, 22]. In some [8] but not all
[9, 10, 21, 22] studies, risks have been higher in chil-
dren delivered with emergency CS than in children
delivered by elective CS, which was also confirmed in
our study. Also studies without any overall positive
association between CS and asthma have shown differ-
ences in effect between elective and emergency CS, or
seen a difference in effect for those born premature or
with low birth weight [11, 13].
The novelty of this study is the sibling control anal-
ysis. Using sibling pairs discordant for mode of
delivery makes it possible to adjust for unmeasured
familial factors, such as maternal characteristics, family
Table 3. Odds ratios and 95% confidence interval of association between mode of delivery and (i) filled prescriptions of asthma medication at age
9–12 years¶ and (ii) asthma diagnosis, in a cohort of children born in Sweden in June 1993–June 1999
Mode of delivery
Model A*
(n = 175 110)
Model B†
(n = 174 381)
Model C‡
(n = 139 610)
Any asthma
medication
Vaginal Ref Ref Ref
Vaginal, instrumental 1.08 (1.01–1.16) 1.09 (1.02–1.17) 1.03 (0.95–1.12)
Caesarean, emergency 1.19 (1.10–1.29) 1.17 (1.08–1.27) 1.14 (1.04–1.25)
Caesarean, elective 1.18 (1.08–1.29) 1.09 (0.99–1.19) 1.06 (0.95–1.18)
b2-Agonists,
corticosteroids
or montelucast,
at least twice
Vaginal Ref Ref Ref
Vaginal, instrumental 1.05 (0.97–1.14) 1.06 (0.98–1.16) 1.02 (0.92–1.13)
Caesarean, emergency 1.18 (1.07–1.30) 1.17 (1.06–1.29) 1.16 (1.03–1.29)
Caesarean, elective 1.24 (1.11–1.38) 1.13 (1.01–1.27) 1.10 (0.97–1.26)
Asthma diagnosis
during follow up
year¶
Vaginal Ref Ref Ref
Vaginal, instrumental 1.20 (1.05–1.37) 1.21 (1.06–1.38) 1.05 (0.91–1.23)
Caesarean, emergency 1.35 (1.16–1.57) 1.32 (1.14–1.54) 1.18 (1.00–1.34)
Caesarean, elective 1.33 (1.12–1.58) 1.17 (0.98–1.40) 1.25 (1.02–1.52)
*Adjusted for gender.
†Adjusted for gender, birth weight and gestational age.
‡Adjusted for gender, birth weight, gestational age, birth order, APGAR score, hypoxia/asphyxia, mother’s age, smoking during pregnancy, mother
living with father of the child, mother’s birth country and mother’s BMI.
¶13th year of life for children born June 1993–May 1996, 10th year of life for children born June 1996–June 1999.
Table 4. Odds ratios and 95% confidence interval of association between mode of delivery and (i) filled prescriptions of asthma medication at
age 9 or 12 years¶ and (ii) asthma diagnosis, in sibling pairs discordant on mode of delivery within a cohort of children born in Sweden in June
1993–June 1999
Mode of delivery Model A* Model B† Model C‡
Any asthma
medication
Vaginal Ref Ref Ref
Vaginal, instrumental 1.02 (0.92–1.13) 1.02 (0.91–1.13) 0.94 (0.82–1.08)
Caesarean, emergency 1.23 (1.06–1.42) 1.19 (1.02–1.39) 1.19 (0.98–1.44)
Caesarean, elective 1.05 (0.89–1.23) 0.91 (0.77–1.08) 0.85 (0.68–1.05)
b2-Agonists,
corticosteroids or
montelucast,
at least twice
Vaginal Ref Ref Ref
Vaginal, instrumental 0.95 (0.83–1.08) 0.95 (0.83–1.08) 0.89 (0.64–1.09)
Caesarean, emergency 1.28 (1.06–1.55) 1.23 (1.02–1.49) 1.24 (0.99–1.60)
Caesarean, elective 1.07 (0.87–1.30) 0.92 (0.74–1.13) 0.82 (0.64–1.09)
Asthma diagnosis
during follow up
year¶
Vaginal Ref Ref Ref
Vaginal, instrumental 1.29 (1.04–1.61) 1.23 (0.99–1.54) 0.85 (0.64–1.13)
Caesarean, emergency 1.81 (1.31–2.49) 1.65 (1.19–2.30) 1.29 (0.84–1.99)
Caesarean, elective 1.10 (0.79–1.51) 0.90 (0.63–1.27) 0.65 (0.42–1.02)
*Adjusted for gender.
†Adjusted for gender, birth weight and gestational age.
‡Adjusted for gender, birth weight, gestational age, birth order, APGAR score, mother’s age, smoking during pregnancy, mother living with father
of the child and mother’s BMI.
¶13th year of life for children born June 1993–May 1996, 10th year of life for children born June 1996–June 1999.
© 2012 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 42 : 1369–1376
1374 C. Almqvist et al
environment and, to some extent, genes, i.e. factors that
are shared between siblings. When using sibling con-
trols, our results showed a borderline association
between emergency CS and asthma, a non-significant
association with point estimates below one between
elective CS and asthma and a statistically significant
difference in effect between emergency and elective CS.
This novel data implies that the association observed
between elective CS and asthma in the cohort analyses
is not likely to be explained by exposure to vaginal mi-
croflora or epigenetic changes. Ha˚kansson et al. also
used the Swedish Medical Birth Register linked to
asthma diagnoses in the NPR [22]. Although they
excluded e.g. children with low Apgar scores, some
neonatal diagnoses and low or high birth weights, their
crude estimates were fairly similar to ours regarding
registered asthma diagnoses. They also made a compari-
son between VD born children with VD and CS siblings
(but not CS emergency and CS elective), concluding no
difference between the groups. We have extended the
analyses further, included data from the PDR, and
adjusted for familial confounding with conditional
analyses within sibling pairs discordant for mode of
delivery. This allowed us to identify a borderline signif-
icance for the effect of emergency CS on asthma.
In high risk pregnancies, there are often maternal or
fetal indications for CS [17] and higher DNA-methyla-
tion have been identified in infants delivered by CS
than infants VD born [16]. Findings on the effect of
CS on asthma and allergic disease have also been pro-
posed to be mediated by the infant’s lack of early
exposure to vaginal microflora, related to the hygiene
hypothesis [9] If so, there would also be a difference
in the effect between elective CS and VD, which was
not the case in our analyses. There was also no effect
of instrumental VD on the risk of asthma in the sibling
analyses. Instrumental deliveries are usually under-
taken at times of prolonged parturition, tired mother
or sick child. An increased risk for asthma would
therefore be suspected in these children, however, it
has also been speculated that these children are pro-
tected by exposure to vaginal microflora and should
therefore have a low asthma risk. In our dataset, this
is not a likely explanation as we did not see any
difference in effect in the sibling analyses.
Strengths of our study include (1) a population-based
longitudinal register based study design in a unified
health care environment with recording in medical regis-
ters of all 9–12 year olds in Sweden; (2) prospectively
collected information on mode of delivery, maternal
background factors and perinatal characteristics, which
preclude recall bias; (3) ascertainment of asthma by
applying predetermined asthma criteria to the NPR (cov-
ers inpatient and outpatient visits but not visits to gen-
eral practitioners) and PDR (full coverage of all
dispensed asthma medication); and (4) a novel sibling
design with identification of sibling pairs discordant for
mode of delivery, which adjusts for maternal characteris-
tics and shared unmeasured family environment includ-
ing socio-economic factors, diet and lifestyle. Within
sibling analyses build on similar concept as the co-twin
analysis, which is commonly used to adjust for unmea-
sured familial factors including maternal characteristics,
family environment and, to some extent, genes. The
matched-sibling design has a number of advantages in
controlling for family factors, which are difficult to mea-
sure and control for in conventional cohort designs. In
addition, we had reasonable statistical power.
There are also inherent limitations in register-based
studies with residual confounding due to factors not
recorded in the registers. We lack information on
genetic factors, many pregnancy associated factors (e.g.
maternal diet and physical activity during pregnancy)
and other factors related to both mode of delivery and
the likelihood of obtaining asthma medication or an
asthma diagnosis (e.g. parental behavioural factors
related to health care utilization). Importantly, the sib-
ling control analysis control for familial (shared genetic
and environmental) factors by design, and therefore
reduce the risk of residual confounding. There are limi-
tations to the sibling design that should be mentioned.
The strict control for shared family factors limits the
analyses to a small subset of the population. Only sib-
ling pairs discordant for mode of delivery as well as
asthma outcomes contribute to the estimate in these
analyses. In the present study, we had 20 493 sibling
pairs which were discordant for mode of delivery, but
only 1005 of these pairs were also discordant for any
asthma medication and 240 pairs discordant for asthma
diagnosis. We find it unlikely that the estimated effect
of mode of delivery on asthma is different in the cohort
and sibling analyses, as each delivery is individually
assessed and observations in both analyses were
retrieved from the same study population. Misclassifica-
tion or underreporting of asthma outcomes may be
related to socio-economic factors, which were con-
trolled for (by design) in the sibling analyses. We have
no reason to believe that misclassification or underre-
porting of asthma outcomes differ by mode of delivery.
Future studies based on larger datasets through link-
age with several national registers and including sibling
controls may have additional power to analyse the asso-
ciation between mode of delivery and asthma. Collec-
tion of objective markers of lung function and measures
of allergic disease in siblings discordant for CS would
also provide important data, as would information on
maternal choice of delivery.
In conclusion, our results, based on the first sibling
control analysis on mode of delivery and asthma, sug-
gest that the association between CS and risk of asthma
© 2012 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 42 : 1369–1376
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are not explained by exposure to the vaginal microflora
or early epigenetic changes, but are subject to the
underlying indications for CS.
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